Clarification of SRNT workgroup guidelines for measures in clinical trials of smoking cessation therapies.
Hughes
John R
JR
Benowitz
Neal
N
Hatsukami
Dorothy
D
Mermelstein
Robin J
RJ
Shiffman
Saul
S
D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D005731:Ganglionic Stimulants / Q000008:administration & dosage / Q000627:therapeutic use; D017408:Guidelines as Topic; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage / Q000627:therapeutic use; D016540:Smoking Cessation; D014029:Tobacco Use Disorder / Q000188:drug therapy; D016896:Treatment Outcome
D005731:Ganglionic Stimulants; D009538:Nicotine